AKCEA THERAPEUTICS INC's ticker is and the CUSIP is 00972L957. A total of 4 filers reported holding AKCEA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $543,000 | -37.9% | 35,300 | -6.6% | 0.00% | – |
| Q2 2019 | $874,000 | +23.4% | 37,800 | +51.2% | 0.00% | – |
| Q1 2019 | $708,000 | -21.7% | 25,000 | -16.7% | 0.00% | – |
| Q4 2018 | $904,000 | +12.3% | 30,000 | +30.4% | 0.00% | – |
| Q3 2018 | $805,000 | -37.1% | 23,000 | -57.4% | 0.00% | – |
| Q2 2018 | $1,280,000 | – | 54,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 14,100 | $494,000 | 0.00% |
| SIMPLEX TRADING, LLC | 183 | $640,000 | 0.00% |
| JPMORGAN CHASE & CO | 23,000 | $805,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |